These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 6687837)
1. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study. Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837 [No Abstract] [Full Text] [Related]
2. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051 [TBL] [Abstract][Full Text] [Related]
3. Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma. Bouillet T; Lepage E; Gisselbrecht C; Boiron M Nouv Rev Fr Hematol (1978); 1990; 32(3):207-9. PubMed ID: 2120675 [TBL] [Abstract][Full Text] [Related]
4. FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization. Ahlgren JD; Smith FP; Cazap E; Estevez RA; Marantz A; Woolley PV; Wilcosky T; Stein J; Schein PS Cancer Treat Rep; 1987 Apr; 71(4):419-20. PubMed ID: 3548959 [No Abstract] [Full Text] [Related]
5. Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment. Hagin GD; Jain A Am J Gastroenterol; 1985 Nov; 80(11):835-7. PubMed ID: 3840327 [TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of stomach cancer]. Gropp C; Havemann K Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730 [TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer. Cocconi G; DeLisi V; Di Blasio B Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233 [TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of adenocarcinoma of the stomach]. Zeitoun P; Lirzin P Ann Gastroenterol Hepatol (Paris); 1984; 20(4):213-7. PubMed ID: 6442117 [No Abstract] [Full Text] [Related]
10. Adjuvant intrahepatic chemotherapy with mitomycin and 5-FU combined with hepatic irradiation in high-risk patients with carcinoma of the colon: a Southwest Oncology Group phase II pilot study. McCracken JD; Weatherall TJ; Oishi N; Janaki L; Boyer C Cancer Treat Rep; 1985 Jan; 69(1):129-31. PubMed ID: 3967254 [TBL] [Abstract][Full Text] [Related]
11. Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study. Bukowski RM; Theodors A; Purvis JD; Budd GT; Weick JK; Gahbauer R Am J Clin Oncol; 1987 Oct; 10(5):376-9. PubMed ID: 3661488 [TBL] [Abstract][Full Text] [Related]
12. Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Lise M; Nitti D; Buyse M; Cartei G; Fornasiero A; Guimaraes dos Santos J; Duez N Recent Results Cancer Res; 1988; 110():36-43. PubMed ID: 3043595 [No Abstract] [Full Text] [Related]
13. Chemotherapy of gastric cancer: a review. Kelsen D Isr J Med Sci; 1988; 24(9-10):557-61. PubMed ID: 3060446 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for colorectal cancer with a combination of 5-fluorouracil, mitomycin C, adriamycin, and cytosine arabinoside: a pilot study. Davis S; Park YK Cancer Treat Rep; 1978 Oct; 62(10):1557-9. PubMed ID: 709556 [TBL] [Abstract][Full Text] [Related]
16. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery]. Kunitomo K; Kawahito M; Miura M; Komi N Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1342-4. PubMed ID: 2437863 [No Abstract] [Full Text] [Related]
17. [A pilot study of the combination of 5-FU and epirubicin for gastric cancer as an adjuvant chemotherapy]. Tsujinaka T; Ogawa M; Shiozaki H; Kido Y; Murata A; Nishijima J; Kobayashi K; Matsuura N; Mori T Gan To Kagaku Ryoho; 1991 May; 18(6):1051-4. PubMed ID: 1903029 [No Abstract] [Full Text] [Related]
18. 5-Fluorouracil versus a combination of BCNU, adriamycin, 5-FU and mitomycin C in advanced gastric cancer: a prospective randomized study of the Italian Clinical Research Oncology Group. De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M Recent Results Cancer Res; 1988; 110():212-8. PubMed ID: 3136519 [No Abstract] [Full Text] [Related]
19. Treatment of hormone-resistant metastatic carcinoma of the prostate with 5-FU, doxorubicin, and mitomycin (FAM'): a preliminary report. Kasimis BS; Moran EM; Miller JB; Forbes KA; Kaneshiro CA; Poblet MT; Williams JL Cancer Treat Rep; 1983 Oct; 67(10):937-9. PubMed ID: 6688755 [TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced gastric carcinoma with mitomycin and doxorubicin. Dalley D; Erlichman C; Fine S Cancer Treat Rep; 1986 Jul; 70(7):897-8. PubMed ID: 3719582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]